Cardiol Therapeutics: HC Wainwright Raises Buy Rating to $9 from $8.

martes, 10 de febrero de 2026, 1:03 pm ET1 min de lectura
CRDL--

Cardiol Therapeutics: HC Wainwright Raises Buy Rating to $9 from $8.

Cardiol Therapeutics: HC Wainwright Raises Buy Rating to $9 from $8.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios